- Home
- MSGM vs QNRX Comparison
MSGM vs QNRX Comparison
Compare MSGM & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSGM | QNRX |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 14.5M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MSGM | QNRX |
|---|---|---|
| Price | $4.48 | $8.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 149.6K | 21.0K |
| Earning Date | 06-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 252.13 | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | ★ $741,000.00 | N/A |
| Revenue This Year | $69.07 | N/A |
| Revenue Next Year | $30.56 | N/A |
| P/E Ratio | $3.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $0.21 |
| 52 Week High | $5.78 | $41.80 |
Technical Indicators
Market Signals| Indicator | MSGM | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.29 | 41.89 |
| Support Level | $2.59 | $8.03 |
| Resistance Level | $4.57 | $8.97 |
| Average True Range (ATR) | 0.53 | 0.37 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 44.12 | 24.53 |
Price Performance
Historical ComparisonAbout MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.